Open Access Open Access  Restricted Access Subscription Access

Non-Ionophore Antibiotics: A Concise Overview of Avoparcin, Bacitracin, Flavomycin, Tylosin, Virginiamycin and Vancomycin

Ambica Prasad M., Ramanajaneyulu D. V., Sony Sharlet E., Muralinath E., Mohan Naidu K., Srinivas Prasad, Jayinder Paul Singh. G, Panjan Ghosh. P., Kalyan C., Archana Jain, Guruprasad M.

Abstract


Non-ionophore antibiotics play an important  role in modern agriculture and animal husbandry as growth promoters and agents to inhibit  and treat bacterial infections especially  in livestock. Among them, avoparcin, bacitracin, flavomycin, tylosin, and virginiamycin are widely used for their effectiveness and safety. This article provides a brief yet informative overview of these non-ionophore antibiotics.


Full Text:

PDF

References


Ahrens, F. (1987). The effect of flavomycin on rumen physiological and

caecal parameters and on milk output and milk constituents in cows:

final report. IS Research Society for Experimental Animal Physiology

and Animal Nutrition.

Alert, H. J., Meier, H. & Poppe, S. (1991). Studies on digestion

physiology after use of flavomycin in the fattening of young beef bulls:

trial report. Trial report, University of Rostock, Germany.

Alexander, M. (1982). Most probable number method for microbial

populations. In Methods of Soil Analysis, Part 2, pp. 815–820.

Agronomy Monograph no. 9, 2nd edn. Madison, WI: American

Society of Agronomy.

Anderson, D. B., McCracken, V. J., Aminov, R. I., Simpson, J. M.,

Mackie, R. I., Verstegen, M. W. A. & Gaskins, H. R. (2000). Gut

microbiology and growth-promoting antibiotics in swine. Nutr Abstr

Rev 70, 101–108.

Attwood, G. T., Klieve, A. V., Ouwerkerk, D. & Patel, B. K. C. (1998).

Ammonia-hyperproducing bacteria from New Zealand ruminants.

Appl Environ Microbiol 64, 1796–1804.

Bailey, G. D. & Love, D. N. (1993). Fusobacterium pseudonecro-

phorum is a synonym for Fusobacterium varium. Int J Syst Bacteriol

, 819–821.

Bauer, F. & Dost, G. (1971). Flavomycin, the first antibiotic intended

exclusively as a food supplement. In The Blue Book for the Veterinary

Profession, vol. 21, pp. 87–92.

Bedo, S., Bodis, L., Ravasz, T. & Kovacs, G. (1984). Effect of growth

promoters on the metabolism of young lambs. Allattenyesztes

Takarmanyozas 33, 139–148.

Cafantaris, B. (1981). The effect of antibiotic supplements on microbial

fermentation in the ruminal fluid in vitro. PhD thesis, University of

Hohenheim, Germany.

Dehority, B. A., Tirabasso, P. A. & Grifo, A. P., Jr (1989). Most-

probable-number procedures for enumerating ruminal bacteria,

including the simultaneous estimation of total and cellulolytic

numbers in one medium. Appl Environ Microbiol 55, 2789–2792.

Edwards, J. E. (2003). Characterisation of the effect of flavomycin on

the rumen microflora. PhD thesis, University of Aberdeen, UK.

Edwards, J. E., Wallace, R. J. & McEwan, N. R. (2002). The growth

promoting mode of action of flavomycin in ruminants. Reprod Nutr

Dev 42 (Suppl. 1), S55.

Edwards, J. E., McEwan, N. R., Travis, A. J. & Wallace, R. J. (2004).

S rDNA library-based analysis of ruminal bacterial diversity.

Antonie Van Leeuwenhoek 86, 263–281.

Edwards, J. E., Bequette, B. J., McKain, N., McEwan, N. R. &

Wallace, R. J. (2005). Influence of flavomycin on microbial numbers,

microbial metabolism and gut tissue protein turnover in the

digestive tract of sheep. Br J Nutr (in press).

Eschenlauer, S. C. P., McKain, N., Walker, N. D., McEwan, N. R.,

Newbold, C. J. & Wallace, R. J. (2002).

Ammonia production by

ruminal microorganisms and enumeration, isolation, and character-

ization of bacteria capable of growth on peptides and amino acids

from the sheep rumen. Appl Environ Microbiol 68, 4925–4931.

Febel, H., Szelenyi, M., Jecsai, J. & Juhasz, B. (1988). Effect of

salinomycin, flavomycin and avoparcin on some physiological traits

of growing lambs, with particular respect to rumen fermentation.

Acta Vet Hung 36, 69–80.

Felsenstein, F. (2002). PHYLIP (Phylogeny Inference Package) version

6a. Seattle: University of Washington.

Galbraith, H., Scaife, J. R. & Lowe, R. H. (1983). Response of growing

bulls to the food additives, salinomycin and flavomycin. Anim Prod

, 527–528.724 Microbiology 151J. E. Edwards and others

• "vancomycin". Merriam-Webster.com Dictionary.

• • "vancomycin - definition of vancomycin in English from the Oxford dictionary". OxfordDictionaries.com. Archived from the original on 20 September 2013. Retrieved 20 January 2016.

• • "Vancomycin". Drugs.com. 2 December 2019. Archived from the original on 24 December 2019. Retrieved 24 December 2019.

• • "Vancomycin Use During Pregnancy". Drugs.com. 27 March 2019. Archived from the original on 6 June 2019. Retrieved 24 December 2019.

• • "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 October 2023.

• • "List of nationally authorised medicinal products" (PDF). European Medicines Agency. 15 October 2020. Archived (PDF) from the original on 25 September 2023. Retrieved 27 April 2023.

• • "Vancocin". The American Society of Health-System Pharmacists. Archived from the original on 6 September 2015. Retrieved 4 September 2015.

• • Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. (February 2011). "Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary". Clinical Infectious Diseases. 52 (3): 285–92. doi:10.1093/cid/cir034. PMID 21217178.

• • Hamilton R (2015). Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition. Jones & Bartlett Learning. p. 91. ISBN 978-1-284-05756-0.

• • "Prescribing medicines in pregnancy database". Australian Government. September 2015. Archived from the original on 8 April 2014.

• • "Vancomycin use while Breastfeeding". Archived from the original on 7 September 2015. Retrieved 5 September 2015.

• • Levine DP (January 2006). "Vancomycin: a history". Clinical Infectious Diseases. 42 (Suppl 1): S5–12. doi:10.1086/491709. PMID 16323120.

• • World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

• • World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.

• • World Health Organization (2019). Critically important antimicrobials for human medicine (6th revision ed.). Geneva: World Health Organization. hdl:10665/312266. ISBN 978-92-4-151552-8.

• • Biondi S, Chugunova E, Panunzio M (2016). From Natural Products to Drugs. Studies in Natural Products Chemistry. Vol. 50. pp. 249–297. doi:10.1016/B978-0-444-63749-9.00008-6. ISBN 978-0-444-63749-9.


Refbacks

  • There are currently no refbacks.